1. Refining the risk for fragile X–associated primary ovarian insufficiency (FXPOI) by FMR1 CGG repeat size
- Author
-
Weiya He, Sarah L. Nolin, Krista Charen, Katharine E. Shelly, Nicole Tortora, Lisa Shubeck, Stephanie L. Sherman, Heather S. Hipp, Bonnie McKinnon, Emily G. Allen, Anne Glicksman, and Ashima Amin
- Subjects
medicine.medical_specialty ,Fragile x ,Obstetrics ,business.industry ,Age at menopause ,Primary ovarian insufficiency ,Menopause, Premature ,Primary Ovarian Insufficiency ,FMR1 ,Article ,Fragile X Mental Retardation Protein ,Increased risk ,Family planning ,Cgg repeat ,Fragile X Syndrome ,medicine ,Humans ,Female ,business ,Risk assessment ,Genetics (clinical) - Abstract
Purpose Approximately 20–30% of women with an FMR1 premutation experience fragile X–associated primary ovarian insufficiency (FXPOI); however, current risk estimates based on repeat size only identify women with the midrange of repeats to be at the highest risk. Methods To better understand the risk by repeat size, we collected self-reported reproductive histories on 1,668 women and divided them into high-resolution repeat size bins of ~5 CGG repeats to determine a more accurate risk for FXPOI in relation to CGG repeat length. Results As previously reported, women with 70–100 CGG repeats were at the highest risk for FXPOI using various statistical models to compare average age at menopause and risk of FXPOI, with women with 85–89 repeats being at the highest risk. Importantly, women with 120 repeats did not have a significantly increased risk for FXPOI compared to women with
- Published
- 2021